NO178500C - Spikamycinderivater, mellomprodukt samt antitumormiddel - Google Patents

Spikamycinderivater, mellomprodukt samt antitumormiddel

Info

Publication number
NO178500C
NO178500C NO922674A NO922674A NO178500C NO 178500 C NO178500 C NO 178500C NO 922674 A NO922674 A NO 922674A NO 922674 A NO922674 A NO 922674A NO 178500 C NO178500 C NO 178500C
Authority
NO
Norway
Prior art keywords
chem
denotes
integer
carbon atoms
given number
Prior art date
Application number
NO922674A
Other languages
English (en)
Norwegian (no)
Other versions
NO178500B (no
NO922674L (no
NO922674D0 (no
Inventor
Noboru Otake
Hiroyuki Kawai
Tomiko Kawasaki
Atsuo Odagawa
Masaru Kamishohara
Teruyuki Sakai
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of NO922674D0 publication Critical patent/NO922674D0/no
Publication of NO922674L publication Critical patent/NO922674L/no
Publication of NO178500B publication Critical patent/NO178500B/no
Publication of NO178500C publication Critical patent/NO178500C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO922674A 1991-07-12 1992-07-08 Spikamycinderivater, mellomprodukt samt antitumormiddel NO178500C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19890391 1991-07-12
JP32684591 1991-11-15
JP4110665A JP2783722B2 (ja) 1991-07-12 1992-04-03 スピカマイシン誘導体およびそれを含む抗腫瘍剤

Publications (4)

Publication Number Publication Date
NO922674D0 NO922674D0 (no) 1992-07-08
NO922674L NO922674L (no) 1993-01-13
NO178500B NO178500B (no) 1996-01-02
NO178500C true NO178500C (no) 1996-04-10

Family

ID=27311786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922674A NO178500C (no) 1991-07-12 1992-07-08 Spikamycinderivater, mellomprodukt samt antitumormiddel

Country Status (16)

Country Link
US (2) US5461036A (ko)
EP (1) EP0525479B1 (ko)
JP (1) JP2783722B2 (ko)
KR (1) KR100253050B1 (ko)
AT (1) ATE159948T1 (ko)
AU (1) AU657551B2 (ko)
CA (1) CA2073567C (ko)
DE (1) DE69222992T2 (ko)
DK (1) DK0525479T3 (ko)
ES (1) ES2111019T3 (ko)
FI (1) FI105815B (ko)
GR (1) GR3025293T3 (ko)
HK (1) HK1001729A1 (ko)
HU (1) HU221808B1 (ko)
NO (1) NO178500C (ko)
SG (1) SG52704A1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7017208B2 (en) * 1995-08-04 2006-03-28 Hill-Rom Services, Inc. Hospital bed
US5905069A (en) * 1998-01-26 1999-05-18 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin or derivatives thereof
ES2208261T3 (es) * 1999-01-22 2004-06-16 Kirin Beer Kabushiki Kaisha Derivados de quinolina y derivados de quinazolina.
AU2001291133A1 (en) 2000-09-20 2002-04-02 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin derivatives
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
HUE041133T2 (hu) * 2002-11-18 2019-05-28 Vicuron Pharmaceuticals Llc Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
WO2005026106A1 (en) * 2003-09-11 2005-03-24 Invista Technologies S.A R.L. Process of hydrocyanation of unsaturated carboxylic acid derivatives
JP4608651B2 (ja) * 2004-06-24 2011-01-12 財団法人ヒューマンサイエンス振興財団 抗ガン作用を有する化合物、その製造方法及び抗ガン剤
US8119829B2 (en) * 2004-09-08 2012-02-21 Invista North America S.A.R.L. Process of hydrocyanation of unsaturated carboxylic acid derivatives
JP5753784B2 (ja) * 2008-10-10 2015-07-22 ダラ・バイオサイエンシズ,インコーポレイテッド スピカマイシン誘導体を用いて疼痛を治療又は予防する方法
EP2597082A1 (de) 2011-11-24 2013-05-29 Symrise AG Verbindungen zur Maskierung eines unangenehmen Geschmacks
CN104822369A (zh) 2012-08-09 2015-08-05 达拉生物科学公司 包含穗霉素衍生物的组合物及其使用方法
WO2015061481A1 (en) 2013-10-23 2015-04-30 Dara Biosciences, Inc. Methods of treating liquid tumors using compositions comprising spicamycin derivatives
CN110386874B (zh) * 2018-04-16 2022-10-04 湖北金鹤化工有限公司 一种12-酮基硬脂酸酯及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155647A (en) 1963-07-24 1964-11-03 Olin Mathieson Septaciding and derivatives thereof
US3264195A (en) * 1963-07-24 1966-08-02 Squibb & Sons Inc Process for the preparation of septacidin and derivatives
US4086416A (en) * 1977-05-17 1978-04-25 Stanford Research Institute Septacidin analogs
JPS59161389A (ja) * 1983-03-07 1984-09-12 Eisai Co Ltd 7−カルボキシメトキシフエニルアセトアミドセフエム誘導体,その製造法およびそれからなる抗菌剤
JPS59161396A (ja) * 1983-03-04 1984-09-12 Kirin Brewery Co Ltd 新規抗生物質スピカマイシン
US4975434A (en) * 1986-05-27 1990-12-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antiviral and anticancer cyclopentenyl cytosine
WO1990015811A1 (en) 1989-06-16 1990-12-27 Kirin Beer Kabushiki Kaisha Spicamycin x and its use

Also Published As

Publication number Publication date
HUT61773A (en) 1993-03-01
NO178500B (no) 1996-01-02
EP0525479B1 (en) 1997-11-05
FI923170A0 (fi) 1992-07-09
HU221808B1 (hu) 2003-01-28
FI105815B (fi) 2000-10-13
KR930002370A (ko) 1993-02-23
US5461036A (en) 1995-10-24
JP2783722B2 (ja) 1998-08-06
KR100253050B1 (ko) 2000-04-15
SG52704A1 (en) 1998-09-28
CA2073567A1 (en) 1993-01-13
DE69222992D1 (de) 1997-12-11
CA2073567C (en) 1998-05-05
US5631238A (en) 1997-05-20
AU1960092A (en) 1993-01-14
NO922674L (no) 1993-01-13
NO922674D0 (no) 1992-07-08
ES2111019T3 (es) 1998-03-01
JPH05186494A (ja) 1993-07-27
FI923170A (fi) 1993-01-13
HU9202285D0 (en) 1992-10-28
ATE159948T1 (de) 1997-11-15
DE69222992T2 (de) 1998-03-05
EP0525479A1 (en) 1993-02-03
HK1001729A1 (en) 1998-07-03
GR3025293T3 (en) 1998-02-27
DK0525479T3 (da) 1998-04-20
AU657551B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
ATE176237T1 (de) Sphingoglycolipid und verwendung davon
NO178500C (no) Spikamycinderivater, mellomprodukt samt antitumormiddel
KR950702431A (ko) 신규한 의약 조성물(novel pharmaceutical compositions)
HK1011689A1 (en) Bis(3,4-dialkylbenzylidene) sorbitol acetals and compositions containing same
FR2678930B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
DE69022675D1 (de) Flüssigkristallzusammensetzung.
DE3875346D1 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
DK0568147T3 (da) Polysiloxanstabilisatorer indeholdende sterisk hindrede phenolgrupper og oxamidgrupper
TW337985B (en) "N-(B-branched alkyl)-1, 2-benzisothiolin, 3ones, their preparation and their use as industrial biocides"
GR3034023T3 (en) Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them.
DE59007487D1 (de) Hydroxyalkancarbonsäure-derivate und deren verwendung.
GB8921792D0 (en) New compositions of matter
DK0502304T3 (da) Middel til permanentbølgning af menneskehår indeholdende alkylpolyglycosider
MY106839A (en) Carboxylate compounds, liquid crystal compositions containing said compounds and liquid crystal elements.
DK606286D0 (da) Anthracyclin-derivater og laegemidler indeholdende disse forbindelser
DK0390138T3 (da) Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel
DE69018552D1 (de) Mesomorphe Verbindung, dieselbe enthaltende flüssigkristalline Zusammensetzung und dieselbe benutzende flüssigkristalline Vorrichtung.
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
ATE24887T1 (de) Cycloaliphatische alkohole.

Legal Events

Date Code Title Description
MK1K Patent expired